Abstract
After myocardial infarction, left ventricular volume and ejection fraction can be assessed by echocardiography, magnetic resonance imaging and radionuclide angiography to guide therapy and determine prognosis. Whether a measured parameter gives the same results irrespective of the method used and the observer who performs the analysis is only partly known. Intra-observer and inter-observer variability were determined for echo and magnetic resonance imaging. Left ventricular ejection fraction measured by these techniques was related to radionuclide angiograms performed in the same period. Intra-observer variability for both echo and MRI was low and in most instances below 5%. Inter-observer variability for the echo and MRI measurements were substantially higher than intra-observer variability. Comparison of the three imaging modalities revealed systematic differences. Therefore, in clinical studies, left ventricular volume and function parameters have to be measured with the same technique and by the same observer in qualified core laboratories.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Produfit WL, Bruschke AVG, Sones FM. Natural history of obstructive coronary artery disease: ten-year study of 601 non-surgical cases. Prog Cardiovasc Dis 1978; 21: 53–78.
White HD, Norris RM, Brown MA, Takayama M, Maslowski A, Bass NM, Orniston JA, Whitlock T. Left ventricular endsystolic volume is the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44–51.
Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SH, MacIntyre WJ, Thomas JD. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Circulation 1994; 90: 2687–94.
Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker G, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med 1992; 327: 669–77.
Lindsay HSJ, Zaman AG, Cowan JC. ACE inhibitors after myocardial infarction: patient selection or treatment for all? Br Heart J 1995; 73: 397–400.
Cohn PF, Levine JA, Bergerson GA, Gorlin R. Reproducibility of the angiographic left ventricular ejection fraction in patients with coronary artery disease. Am Heart J 1974; 88: 713–20.
Wackers FJ, Berger HJ, Johnstone DE, Goldman L, Reduto LA, Langou RA, Gottschalk A, Zaret BL. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am J Cardiol 1979; 43: 1159–65.
Doherty III NE, Seelos K, Suzuki J, Caputo GR, O'Sullivan M, Sobol SM, Cavero P, Chatterjee K, Parmley WW, Higgins CB. Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. J Am Coll Cardiol 1992; 19: 1294–302.
Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: recognition by two-dimensional echocardiography. N Engl J Med 1979; 300: 57–64.
Sharpe N, Smith H, Murphy J., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988; i: 255–9.
St John Sutton M, Pfeffer MA, Plappert T, Rouleau J, Moye LA, Dagenans GR, Lamas GA, Klein M, Sussex B, Goldman GR, Menapace FJ, Parker JO, Lewis S, Sestier F, Gordon DF, McEwan P, Bernstein V, Braunwald E. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. Circ 1994; 89: 68–75.
Baur LHB, Schipperheyn JJ, Baan J, van der Laarse A, Buis B, van der Wall EE, Manger Cats V, van Dijk A, Blokland JAK, Frölich M, Bruschke AVG: Influence of angiotensin converting enzyme inhibition on pump function and cardiac contractility in patients with chronic congestive heart failure. Br Heart J 1991; 65: 137–42.
Underwood R, Gibson C, Tweddel A, Flint J on behalf of the British Nuclear Cardiology Group. A survey of nuclear cardiology practice in Great Brittain. Br Heart J 1992; 67: 273–7.
Ray SG, Metcalfe MJ, Oldroy KG, Pye M, Martin W, Christie J, Dargie HJ, Cobbe SM. Do radionuclide and echocardiographic techniques give a universal cut off value for left ventricular ejection fraction that can be used to select patients for treatment with ACE inhibitors after myocardial infarction? Br Heart J 1995; 73: 466–9.
Pietro DA, Gene Voelkel A, Ray BJ, Parisi AF: Reproducibility of echocardiography. Chest 1981; 79: 29–32.
Gordon EP, Schnittger I, Fitzgerald P, Williams P, Popp RL. Reproducibility of left ventricular volumes with two dimensional echocardiography. JACC 1983; 2: 506–13.
Kuecherer HF, Kee LL, Modin G, Cheitlin MD, Schiller NB. Echocardiography in serial evaluation of left ventricular systolic and diastolic function: Importance of image acquisition, quantitation and physiologic variability in clinical and investigational applications. J Am Soc Echo 1991; 4: 203–14.
Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H: Recommendations for quantitation of the left ventricle by two dimensional echocardiography. J Am Soc Echo 1989; 2: 358–67.
Reichek N, Helak J, Plappert T, St John Sutton M, Weber KT. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation 1983; 67: 348–52.
Geest van der RJ, Jansen E, Buller VGM, Reiber JHC. Automated detection of left ventricular epi- and endocardial contours in short-axis MR images. Comp Cardiol 1994. Bethesda, Maryland: IEEE Computer Society Press, 1994: 245–8.
Van Dijkman PRM, Hold KM, van der Laarse A, Holman ER, Ozdemir HI, van der Nat TH, de Roos A, van der Wall EE. Sequential analysis of infarcted and normal myocardium in piglets using in vivo gadolinium enhanced MR images. Magn Res Imaging 1993; 11: 207–18.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307–10.
Gordon EP, Schnittger I, Fitzgerald PJ, Williams P, Popp RL. Reproducibility of left ventricular volumes by two-dimensional echocardiography. J Am Coll Cardiol 1983; 2: 506–13.
Amico AF, Lichtenberg GS, Reisner SA, Stone CK, Schwartz RG, Meltzer RS. Superiority of visual versus computerized echocardiographic estimation of randionuclide left ventricular ejection fraction. Am Heart J 1989; 118: 1259–65.
Vandenberg B, Rath LS, Stuhlmuller P, Melton HE, Skorton DJ. Estimation of left ventricular area with an on-line, semiautomated echocardiographic edge detection system. Circulation 1992; 86: 159–66.
Martin RP, Rakowski H, Kleiman JH, Beaver W, London E, Poop RL. Reliability and reproducibility of two dimensional echocardiographic measurement of the stenotic mitral valve orifice area. Am J Cardiol 1979; 43: 560–8.
Force TL, Folland ED, Aebischer N, Sharma S, Parisi AF. In: Marcus ML, Schelbert HR, Skorton DJ, Wolf GL (eds) Cardiac Imaging. Philadelphia: W.B. Saunders 1991: 374–401.
Dumesnil JG, Shoucri RM. Effect of the geometry of the left ventricle on the calculation of ejection fraction. Circulation 1982; 65: 91–8.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baur, L.H.B., Schipperheyn, J.J., van der Velde, E.A. et al. Reproducibility of left ventricular size, shape and mass with echocardiography, magnetic resonance imaging and radionuclide angiography in patients with anterior wall infarction. Int J Cardiac Imag 12, 233–240 (1996). https://doi.org/10.1007/BF01797736
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01797736